Blood vessel injury may spur disease's fatal second phase

Science. 2020 Jun 5;368(6495):1039-1040. doi: 10.1126/science.368.6495.1039.
No abstract available

Publication types

  • News

MeSH terms

  • Blood Coagulation
  • Blood Vessels / pathology*
  • Blood Vessels / virology*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / pathology*
  • Endothelial Cells / pathology
  • Endothelial Cells / virology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Inflammation / pathology
  • Inflammation / virology
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / pathology*
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity
  • Thrombosis / prevention & control
  • Thrombosis / virology*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors